Bellevue Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-39,207
| Closed | -$4.65M | – | 187 |
|
|
2022
Q1 | $4.65M | Buy |
39,207
+1,200
| +3% | +$142K | 0.05% | 119 |
|
|
2021
Q4 | $5.24M | Buy |
38,007
+20,507
| +117% | +$2.83M | 0.05% | 125 |
|
|
2021
Q3 | $2.43M | Sell |
17,500
-18,500
| -51% | -$2.57M | 0.02% | 144 |
|
|
2021
Q2 | $3.5M | Hold |
36,000
| – | – | 0.03% | 136 |
|
|
2021
Q1 | $2.46M | Buy |
36,000
+23,500
| +188% | +$1.61M | 0.03% | 136 |
|
|
2020
Q4 | $1.07M | Sell |
12,500
-12,000
| -49% | -$1.03M | 0.01% | 154 |
|
|
2020
Q3 | $1.59M | Buy |
+24,500
| New | +$1.59M | 0.02% | 147 |
|
|
2020
Q2 | – | Sell |
-24,800
| Closed | -$844K | – | 231 |
|
|
2020
Q1 | $844K | Buy |
24,800
+2,100
| +9% | +$71.5K | 0.02% | 144 |
|
|
2019
Q4 | $1.24M | Buy |
+22,700
| New | +$1.24M | 0.02% | 148 |
|